STOCK TITAN

[Form 4] Absci Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Absci Corp. (ABSI) Form 4: Chief Innovation Officer Andreas Busch purchased 50,000 common shares on 07/28/2025 at $3.04 per share in an open-market transaction in accordance with company trading policies. The transaction cost is approximately $152,000 and raises Busch’s direct beneficial ownership to 327,264 shares. No derivative securities were reported. The filing is a single-insider submission, electronically signed by attorney-in-fact Shelby Walker.

Open-market insider buying—particularly by a C-suite executive—can signal management confidence and reduce free float by a marginal amount. Investors often view such purchases as a modestly positive indicator, especially when executed with personal funds rather than via option exercises.

Absci Corp. (ABSI) Modulo 4: Il Chief Innovation Officer Andreas Busch ha acquistato 50.000 azioni ordinarie il 28/07/2025 al prezzo di 3,04 $ per azione in una transazione di mercato aperto, in conformità con le politiche aziendali di trading. Il costo della transazione è di circa 152.000 $ e porta la proprietà diretta di Busch a 327.264 azioni. Non sono stati segnalati titoli derivati. La comunicazione è una singola dichiarazione insider, firmata elettronicamente dall’avvocato delegato Shelby Walker.

L’acquisto da parte di un insider sul mercato aperto—specialmente da un dirigente di alto livello—può indicare la fiducia del management e ridurre leggermente il flottante. Gli investitori spesso interpretano tali acquisti come un segnale moderatamente positivo, soprattutto quando effettuati con fondi personali e non tramite esercizio di opzioni.

Absci Corp. (ABSI) Formulario 4: El Director de Innovación, Andreas Busch, compró 50,000 acciones ordinarias el 28/07/2025 a $3.04 por acción en una transacción de mercado abierto, conforme a las políticas de negociación de la empresa. El costo de la transacción es aproximadamente $152,000 y eleva la propiedad directa beneficiaria de Busch a 327,264 acciones. No se reportaron valores derivados. La presentación es una declaración de un solo insider, firmada electrónicamente por el apoderado Shelby Walker.

La compra de insiders en mercado abierto—especialmente por un ejecutivo de nivel C—puede señalar confianza en la dirección y reducir marginalmente el free float. Los inversores suelen ver estas compras como un indicador modestamente positivo, especialmente cuando se realizan con fondos personales en lugar de mediante el ejercicio de opciones.

Absci Corp. (ABSI) Form 4: 최고혁신책임자 Andreas Busch가 2025년 7월 28일 회사 거래 정책에 따라 공개 시장에서 50,000 보통주를 주당 $3.04에 매수했습니다. 거래 비용은 약 $152,000이며, Busch의 직접적 실질 소유 주식 수는 327,264주로 증가했습니다. 파생 증권은 보고되지 않았습니다. 제출 서류는 단일 내부자 제출로, 대리인 Shelby Walker가 전자 서명했습니다.

공개 시장에서의 내부자 매수—특히 C-레벨 임원의 경우—는 경영진의 신뢰를 나타내고 유통 주식 수를 다소 줄일 수 있습니다. 투자자들은 개인 자금으로 이루어진 이러한 매수를 옵션 행사보다 긍정적인 신호로 보는 경향이 있습니다.

Absci Corp. (ABSI) Formulaire 4 : Le Chief Innovation Officer Andreas Busch a acheté 50 000 actions ordinaires le 28/07/2025 au prix de 3,04 $ par action lors d’une transaction sur le marché ouvert, conformément aux politiques de négociation de l’entreprise. Le coût de la transaction est d’environ 152 000 $ et porte la propriété directe bénéficiaire de Busch à 327 264 actions. Aucun titre dérivé n’a été déclaré. Le dépôt est une déclaration d’initié unique, signée électroniquement par le mandataire Shelby Walker.

L’achat d’initiés sur le marché ouvert — notamment par un cadre dirigeant — peut signaler la confiance de la direction et réduire légèrement le flottant. Les investisseurs perçoivent souvent ces achats comme un indicateur modérément positif, surtout lorsqu’ils sont effectués avec des fonds personnels plutôt que par exercice d’options.

Absci Corp. (ABSI) Formular 4: Chief Innovation Officer Andreas Busch kaufte am 28.07.2025 50.000 Stammaktien zu je 3,04 $ in einer Transaktion am offenen Markt gemäß den Handelsrichtlinien des Unternehmens. Die Transaktionskosten belaufen sich auf etwa 152.000 $ und erhöhen Buschs direkten wirtschaftlichen Anteil auf 327.264 Aktien. Es wurden keine Derivate gemeldet. Die Meldung ist eine Einzel-Insider-Einreichung, elektronisch unterzeichnet vom Bevollmächtigten Shelby Walker.

Insider-Käufe am offenen Markt – insbesondere durch einen C-Level-Manager – können ein Zeichen für das Vertrauen des Managements sein und die Streuung geringfügig reduzieren. Investoren betrachten solche Käufe oft als leicht positives Signal, besonders wenn sie mit eigenen Mitteln und nicht durch Optionsausübung getätigt werden.

Positive
  • 50,000-share open-market purchase by the Chief Innovation Officer indicates management confidence.
  • Ownership increase to 327,264 shares improves executive-shareholder alignment.
Negative
  • None.

Insights

TL;DR: Insider spends ~$152k on open-market shares, modest but confidence-boosting.

The CIO’s cash purchase at $3.04 lifts his stake by 18% to 327k shares. While the dollar value is small relative to Absci’s market cap, open-market buying—versus option exercise—shows incremental conviction at current price levels and can help align executive and shareholder interests. Historically, such insider activity tends to correlate with short-term support for the stock, though magnitude limits impact.

TL;DR: Transaction strengthens alignment; no governance concerns noted.

The Form 4 follows Section 16 rules, is timely, and discloses a straightforward purchase. Personal share accumulation by an officer enhances skin-in-the-game and signals confidence in strategic direction. No red flags—such as patterned selling or derivative hedging—are evident. Impact is positive, albeit not material to control dynamics.

Absci Corp. (ABSI) Modulo 4: Il Chief Innovation Officer Andreas Busch ha acquistato 50.000 azioni ordinarie il 28/07/2025 al prezzo di 3,04 $ per azione in una transazione di mercato aperto, in conformità con le politiche aziendali di trading. Il costo della transazione è di circa 152.000 $ e porta la proprietà diretta di Busch a 327.264 azioni. Non sono stati segnalati titoli derivati. La comunicazione è una singola dichiarazione insider, firmata elettronicamente dall’avvocato delegato Shelby Walker.

L’acquisto da parte di un insider sul mercato aperto—specialmente da un dirigente di alto livello—può indicare la fiducia del management e ridurre leggermente il flottante. Gli investitori spesso interpretano tali acquisti come un segnale moderatamente positivo, soprattutto quando effettuati con fondi personali e non tramite esercizio di opzioni.

Absci Corp. (ABSI) Formulario 4: El Director de Innovación, Andreas Busch, compró 50,000 acciones ordinarias el 28/07/2025 a $3.04 por acción en una transacción de mercado abierto, conforme a las políticas de negociación de la empresa. El costo de la transacción es aproximadamente $152,000 y eleva la propiedad directa beneficiaria de Busch a 327,264 acciones. No se reportaron valores derivados. La presentación es una declaración de un solo insider, firmada electrónicamente por el apoderado Shelby Walker.

La compra de insiders en mercado abierto—especialmente por un ejecutivo de nivel C—puede señalar confianza en la dirección y reducir marginalmente el free float. Los inversores suelen ver estas compras como un indicador modestamente positivo, especialmente cuando se realizan con fondos personales en lugar de mediante el ejercicio de opciones.

Absci Corp. (ABSI) Form 4: 최고혁신책임자 Andreas Busch가 2025년 7월 28일 회사 거래 정책에 따라 공개 시장에서 50,000 보통주를 주당 $3.04에 매수했습니다. 거래 비용은 약 $152,000이며, Busch의 직접적 실질 소유 주식 수는 327,264주로 증가했습니다. 파생 증권은 보고되지 않았습니다. 제출 서류는 단일 내부자 제출로, 대리인 Shelby Walker가 전자 서명했습니다.

공개 시장에서의 내부자 매수—특히 C-레벨 임원의 경우—는 경영진의 신뢰를 나타내고 유통 주식 수를 다소 줄일 수 있습니다. 투자자들은 개인 자금으로 이루어진 이러한 매수를 옵션 행사보다 긍정적인 신호로 보는 경향이 있습니다.

Absci Corp. (ABSI) Formulaire 4 : Le Chief Innovation Officer Andreas Busch a acheté 50 000 actions ordinaires le 28/07/2025 au prix de 3,04 $ par action lors d’une transaction sur le marché ouvert, conformément aux politiques de négociation de l’entreprise. Le coût de la transaction est d’environ 152 000 $ et porte la propriété directe bénéficiaire de Busch à 327 264 actions. Aucun titre dérivé n’a été déclaré. Le dépôt est une déclaration d’initié unique, signée électroniquement par le mandataire Shelby Walker.

L’achat d’initiés sur le marché ouvert — notamment par un cadre dirigeant — peut signaler la confiance de la direction et réduire légèrement le flottant. Les investisseurs perçoivent souvent ces achats comme un indicateur modérément positif, surtout lorsqu’ils sont effectués avec des fonds personnels plutôt que par exercice d’options.

Absci Corp. (ABSI) Formular 4: Chief Innovation Officer Andreas Busch kaufte am 28.07.2025 50.000 Stammaktien zu je 3,04 $ in einer Transaktion am offenen Markt gemäß den Handelsrichtlinien des Unternehmens. Die Transaktionskosten belaufen sich auf etwa 152.000 $ und erhöhen Buschs direkten wirtschaftlichen Anteil auf 327.264 Aktien. Es wurden keine Derivate gemeldet. Die Meldung ist eine Einzel-Insider-Einreichung, elektronisch unterzeichnet vom Bevollmächtigten Shelby Walker.

Insider-Käufe am offenen Markt – insbesondere durch einen C-Level-Manager – können ein Zeichen für das Vertrauen des Managements sein und die Streuung geringfügig reduzieren. Investoren betrachten solche Käufe oft als leicht positives Signal, besonders wenn sie mit eigenen Mitteln und nicht durch Optionsausübung getätigt werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Busch Andreas

(Last) (First) (Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BLVD

(Street)
VANCOUVER WA 98683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Innovation Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/28/2025 P(1) 50,000 A $3.04 327,264 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Open market purchase of shares in accordance with Issuer's trading policies.
Remarks:
/s/ Shelby Walker, attorney-in-fact 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Absci Corp

NASDAQ:ABSI

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

378.85M
113.55M
15.17%
56.65%
16.6%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER